Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.
Also called NCT07588438
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Sponsor
- Las Rías Medical Center
- Registry
-
NCT07588438
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Paraguay
- Registry status
- Recruiting
Technical summary
Registry record NCT07588438. Non-randomized; no masking; primary purpose treatment. Start 2026-07-27 (anticipated); primary completion 2027-08-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
- Acronym
- REAL-TIRZEPY
- Condition
- Obesity
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Tirzepatide (LIPOLESS de Laboratorio de Productos Eticos C.E.I.S.A.)
- Lead sponsor
- Las Rías Medical Center
- Collaborator
- LABORATORIO DE PRODUCTOS ETICOS C.E.I.S.A
Record details
- Record id
cardio:ct-nct07588438- Content hash
1635e7af3f02f7bd75853500dd39b0a8f090c82560ac722dcf40d98f6768d8e9